advertisement
11.14 Investigational drugs; pharmacological experiments (135)
Showing records 1 to 25
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments82430 Latanoprost uptake and release from commercial contact lenses
Horne RR
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19
82239 Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment
Mittal N
International Journal of Biological Macromolecules 2019; 139: 1252-1262
82282 Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma
Fernández-Albarral JA
International journal of molecular sciences 2019; 20:
82535 Rho-kinase inhibitors in the management of glaucoma
Berrino E
Expert Opinion on Therapeutic Patents 2019; 29: 817-827
82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Savinainen A
Experimental Eye Research 2019; 189: 107836
82505 Cystoid macular edema with prostaglandin analogue use after uneventful cataract surgery in glaucoma patients
Fakhraie G
Journal of Cataract and Refractive Surgery 2019; 45: 1436-1445
82315 Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018)
Angeli A
Expert Opinion on Therapeutic Patents 2019; 29: 793-803
82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Ha JY
Chonnam medical journal 2019; 55: 156-162
82313 The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells
Uchida T
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 535-541
82244 Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice
Millar JC
Experimental Eye Research 2019; 188: 107763
82000 Evaluating the Effects of an Ophthalmic Solution of Coenzyme Q10 and Vitamin E in Open-Angle Glaucoma Patients: A Study Protocol
Quaranta L
Advances in Therapy 2019; 36: 2506-2514
82309 Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension
Heo JH
Journal of managed care & specialty pharmacy 2019; 25: 1001-1010
82641 Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey
Savinainen A
Experimental Eye Research 2019; 189: 107836
82273 Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595
Bonardi A
Expert Opinion on Therapeutic Patents 2019; 29: 753-759
82843 Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)
Guo Y
Translational vision science & technology 2019; 8: 47
82608 Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Lanza M
Frontiers in pharmacology 2019; 10: 1117
82372 Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma
Choi KJ
Biochemical Pharmacology 2019; 169: 113632
82163 Novel therapies for glaucoma: a patent review (2013-2019)
Guglielmi P
Expert Opinion on Therapeutic Patents 2019; 29: 769-780
82222 Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery
Sheppard JD
Clinical Ophthalmology 2019; 13: 1279-1288
82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550
82528 A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
Krishnan A
Journal of Neuroinflammation 2019; 16: 184
82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 781-792
82877 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Aillegas NA
Pharmacological Reports 2019; 71: 794-797
82757 The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial
Chițu I
Romanian journal of ophthalmology 2019; 63: 222-230
82728 Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Sinha S
Expert Opinion in Pharmacotherapy 2020; 21: 39-45